73111-01-0

Basic information

• Product Name: 4',5,7-TRIACETOXYFLAVANONE
• Synonyms: 4',5,7-TRIACETOXYFLAVANONE
• CAS NO: 73111-01-0
• Molecular Formula: C₂₁H₁₈O₈
• Molecular Weight: 384.34
• Mol File: 73111-01-0.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4',5,7-TRIACETOXYFLAVANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 4',5,7-TRIACETOXYFLAVANONE(73111-01-0)
• EPA Substance Registry System: 4',5,7-TRIACETOXYFLAVANONE(73111-01-0)

Safety Data

• Hazardous Substances Data: 73111-01-0(Hazardous Substances Data)

Upstream product

• 480-41-1 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chroman-4-on 
• 108-24-7 acetic anhydride 
• 480-41-1 naringenin 
• 108-22-5 Isopropenyl acetate 
• 75-36-5 acetyl chloride 
• 42385-90-0 4,2',4',6'-tetraacetoxy-trans-chalcone 

Downstream Products

• 1141487-32-2 2-(4-acetoxyphenyl)-8-(3-methylbut-2-enyl)-4-oxochroman-5,7-diyl diacetate 
• 53846-50-7 sophoraflavanone B 
• 39953-45-2 Selinondiacetat 
• 749256-67-5 (±)-5,4'-diacetoxy-7-methoxyflavan-4-one 
• 520-29-6 5,4'-dihydroxy-7-methoxyflavanone 
• 517892-90-9 (±)-5,7-diacetoxy-4'-hydroxyflavan-4-one 
• 28116-98-5 rac-5,7-dihydroxy-2-[4-(3-methylbut-2-enyloxy)phenyl]chroman-4-one 
• 1082704-39-9 C₁₇H₁₄O₆ 
• 64670-92-4 5,7-diacetoxy-2-(4-acetoxy-phenyl)-chroman 
• 3316-46-9 apigenin triacetate 

Relevant articles and documents

Peracetylation of polyphenols under rapid and mild reaction conditions

Structural modifications are an important tool for studying the properties of naturally occurring polyphenols. Regarding the preparation of acetyl esters, the presence of hydroxyl groups stabilized by intramolecular hydrogen bonds may pose an obstacle for

ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE

Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.

MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME

Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.